A. Muth

Adoptive Immunotherapy of Acute Leukemia and Acute Phase Chronic Myeloid Leukemia after Allogeneic Bone Marrow Transplantation

G. Ledderose, E. Holler, R. Munker, 2001 .

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

A. Zander, F. Ayuk, R. Erttmann, 2008, Bone Marrow Transplantation.

Discontinued at Least 90 Days Before the Procedure Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Interferon-? Before Allogeneic Bone Marrow Transplantation in Chronic

A. Zander, A. Gratwohl, A. Tobler, 2013 .

Interferon- Before Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure

W. Siegert, H. Heimpel, A. Zander, 1999 .